Activist investor White Tale on Monday demanded three seats on Clariant's board and an independent strategic review of the Swiss speciality chemicals group after thwarting its plans to merge with U.S. peer Huntsman in a $20 billion deal. More »
Activist investors who oppose Swiss specialty chemicals maker Clariant's proposed $20 billion merger with U.S.-based Huntsman have boosted their stake to 20 percent, the Swiss stock exchange said on Friday, after Reuters reported the increased holding on Thurs... More »
Activist investors seeking to block specialty chemical maker Clariant's $20 billion merger with Huntsman Corp have boosted their stake in the Swiss group above 20 percent, triggering an official disclosure filing, a source familiar with the matter said. More »
U.S. President Donald Trump speaks at the annual Friends of Ireland St. Patrick’s Day lunch honoring Irish Taoiseach Enda Kenny in the U.S. Capitol in Washington, U.S., March 16, 2017. REUTERS/Kevin Lamarque President Donald Trump’s proposal to do away with th... More »
By Liz MerminLONDON (Thomson Reuters Foundation) – Shoppers lured by a bargain-priced T-shirt but concerned about whether the item is free of slave l More »
German chemical maker Lanxess (LXSG.DE) said on Monday it was confident that no rival bidder would trump its $2.7 billion takeover offer for U.S. peer Chemtura (CHMT.N). More »
A logo of Lanxess is seen next to dark clouds at Cologne Bonn airport March 27, 2015. REUTERS/Wolfgang Rattay Lanxess AG (LXSG.DE) is to buy U.S. speciality chemical company Chemtura (CHMT.N) for 2.4 billion euros ($2.69 billion) including debt in the German c... More »
BOSTON Sitting on a double-digit loss that is the deepest in his firm’s history, billionaire investor Bill Ackman on Tuesday told investors that he made mistakes last year in not cutting two big positions but said he sees plenty of new investment opportunities... More »
BOSTON Billionaire hedge fund investor William Ackman, whose funds have suffered double-digit losses this year, on Tuesday told investors that 2015 could be his firm’s worst ever, but said clients are generally sticking with him. “If the year finishes with our... More »
We use cookies!
By using this site you agree to the use of cookies, more info.